Holoxan and malignant neoplasm progression Patient Reports February 12, 2012

Holoxan Side Effects Report #5813332-7
Holoxan side effect was reported by a Consumer or non-health professional from FRANCE on July 08, 2008. Female patient, 47 years of age, was diagnosed with ovarian cancer and was treated with Holoxan. After drug was administered, patient experienced the following side effects: encephalopathy, malignant neoplasm progression. Holoxan dosage: unknown. During the same period patient was treated with UROMITEXAN, VEPESID. Patient was hospitalized. Patient died on 05/20/2008.

Holoxan Side Effects Report #5403295-0
Holoxan side effect was reported by a Consumer or non-health professional from FRANCE on July 25, 2007. Female patient, 57 years of age, was diagnosed with leiomyosarcoma and was treated with Holoxan. After drug was administered, patient experienced the following side effects: encephalopathy, hyperaesthesia, malignant neoplasm progression, myoclonus. Holoxan dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, DETICENE, UROMITEXAN, ZOFRAN, LEVOTHYROXINE, ATENOLOL, TAREG. Patient was hospitalized. Patient died on 06/27/2007.

Holoxan Side Effects Report #4870807-5
Holoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2005. Female patient, 63 years of age, was diagnosed with bladder cancer recurrent and was treated with Holoxan. After drug was administered, patient experienced the following side effects: confusional state, convulsion, disorientation, encephalopathy, malignant neoplasm progression, motor dysfunction. Holoxan dosage: unknown. During the same period patient was treated with NEURONTIN, PLANUM, PASPERTIN, TRAMAL, ACETYLCYSTEINE, SOLEDUM, DECORTIN. Patient died on 05/15/2005.

Holoxan Side Effects Report #5018916-4
Holoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2005. Female patient, 63 years of age, was diagnosed with bladder cancer recurrent and was treated with Holoxan. After drug was administered, patient experienced the following side effects: confusional state, convulsion, disorientation, encephalopathy, malignant neoplasm progression, motor dysfunction. Holoxan dosage: unknown. During the same period patient was treated with NEURONTIN, PLANUM, PASPERTIN, ETOPOSIDE, TRAMADOL, ACETYLCYSTEINE, SOLEDUM, DECORTIN. Patient died on 05/15/2005.